Literature DB >> 30801848

Genetic interactions between Ror2 and Wnt9a, Ror1 and Wnt9a and Ror2 and Ror1: Phenotypic analysis of the limb skeleton and palate in compound mutants.

Martina Weissenböck1, Richard Latham1, Michiru Nishita2, Lena Ingeborg Wolff3, Hsin-Yi Henry Ho4, Yasuhiro Minami2, Christine Hartmann3.   

Abstract

Mutations in the human receptor tyrosine kinase ROR2 are associated with Robinow syndrome (RRS) and brachydactyly type B1. Amongst others, the shortened limb phenotype associated with RRS is recapitulated in Ror2-/- mutant mice. In contrast, Ror1-/- mutant mice are viable and show no limb phenotype. Ror1-/- ;Ror2-/- double mutants are embryonic lethal, whereas double mutants containing a hypomorphic Ror1 allele (Ror1hyp ) survive up to birth and display a more severe shortened limb phenotype. Both orphan receptors have been shown to act as possible Wnt coreceptors and to mediate the Wnt5a signal. Here, we analyzed genetic interactions between the Wnt ligand, Wnt9a, and Ror2 or Ror1, as Wnt9a has also been implicated in skeletal development. Wnt9a-/- single mutants display a mild shortening of the long bones, whereas these are severely shortened in Ror2-/- mutants. Ror2-/- ;Wnt9a-/- double mutants displayed even more severely shortened long bones, and intermediate phenotypes were observed in compound Ror2;Wnt9a mutants. Long bones were also shorter in Ror1hyp/hyp ;Wnt9a-/- double mutants. In addition, Ror1hyp/hyp ;Wnt9a-/- double mutants displayed a secondary palate cleft phenotype, which was not present in the respective single mutants. Interestingly, 50% of compound mutant pups heterozygous for Ror2 and homozygous mutant for Ror1 also developed a secondary palate cleft phenotype.
© 2019 Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Ror1; Ror2; Wnt9a; chondrogenesis; endochondral ossification; limb skeleton; secondary cleft palate

Mesh:

Substances:

Year:  2019        PMID: 30801848      PMCID: PMC7340625          DOI: 10.1111/gtc.12676

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  6 in total

1.  Whole-exome sequencing identified compound heterozygous variants in ROR2 gene in a fetus with Robinow syndrome.

Authors:  Kai Yang; Jianjiang Zhu; Ya Tan; Xiaofei Sun; Huawei Zhao; Guodong Tang; Dongliang Zhang; Hong Qi
Journal:  J Clin Lab Anal       Date:  2019-10-16       Impact factor: 2.352

2.  Heterozygous Recurrent Mutations Inducing Dysfunction of ROR2 Gene in Patients With Short Stature.

Authors:  Baoheng Gui; Chenxi Yu; Xiaoxin Li; Sen Zhao; Hengqiang Zhao; Zihui Yan; Xi Cheng; Jiachen Lin; Haiyang Zheng; Jiashen Shao; Zhengye Zhao; Lina Zhao; Yuchen Niu; Zhi Zhao; Huizi Wang; Bobo Xie; Xianda Wei; Chunrong Gui; Chuan Li; Shaoke Chen; Yi Wang; Yanning Song; Chunxiu Gong; Terry Jianguo Zhang; Xin Fan; Zhihong Wu; Yujun Chen; Nan Wu
Journal:  Front Cell Dev Biol       Date:  2021-04-14

Review 3.  The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease.

Authors:  Mitsuharu Endo; Koki Kamizaki; Yasuhiro Minami
Journal:  Front Cell Dev Biol       Date:  2022-04-13

4.  Obstetrical Challenges in Robinow Syndrome.

Authors:  Yingao Zhang; Marco Casanova; Matthew Shanahan; V Reid Sutton; Karin Fox
Journal:  Case Rep Obstet Gynecol       Date:  2022-07-22

Review 5.  Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.

Authors:  Hanna Karvonen; Harlan Barker; Laura Kaleva; Wilhelmiina Niininen; Daniela Ungureanu
Journal:  Cells       Date:  2019-08-02       Impact factor: 6.600

Review 6.  Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis.

Authors:  Núria Martínez-Gil; Nerea Ugartondo; Daniel Grinberg; Susanna Balcells
Journal:  Genes (Basel)       Date:  2022-01-13       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.